- Home
- NNVC vs CLSD Comparison
NNVC vs CLSD Comparison
Compare NNVC & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNVC
- CLSD
- Stock Information
- Founded
- NNVC 2005
- CLSD 2011
- Country
- NNVC United States
- CLSD United States
- Employees
- NNVC N/A
- CLSD N/A
- Industry
- NNVC Biotechnology: Pharmaceutical Preparations
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- NNVC Health Care
- CLSD Health Care
- Exchange
- NNVC Nasdaq
- CLSD Nasdaq
- Market Cap
- NNVC 24.8M
- CLSD 20.4M
- IPO Year
- NNVC N/A
- CLSD 2016
- Fundamental
- Price
- NNVC $1.26
- CLSD $2.75
- Analyst Decision
- NNVC
- CLSD Hold
- Analyst Count
- NNVC 0
- CLSD 4
- Target Price
- NNVC N/A
- CLSD $75.00
- AVG Volume (30 Days)
- NNVC 477.8K
- CLSD 42.9K
- Earning Date
- NNVC 11-14-2025
- CLSD 11-14-2025
- Dividend Yield
- NNVC N/A
- CLSD N/A
- EPS Growth
- NNVC N/A
- CLSD N/A
- EPS
- NNVC N/A
- CLSD N/A
- Revenue
- NNVC N/A
- CLSD $3,329,000.00
- Revenue This Year
- NNVC N/A
- CLSD $98.20
- Revenue Next Year
- NNVC $133.33
- CLSD $213.77
- P/E Ratio
- NNVC N/A
- CLSD N/A
- Revenue Growth
- NNVC N/A
- CLSD N/A
- 52 Week Low
- NNVC $0.94
- CLSD $2.54
- 52 Week High
- NNVC $2.23
- CLSD $17.10
- Technical
- Relative Strength Index (RSI)
- NNVC 38.51
- CLSD 33.87
- Support Level
- NNVC $1.37
- CLSD $2.54
- Resistance Level
- NNVC $1.56
- CLSD $4.00
- Average True Range (ATR)
- NNVC 0.21
- CLSD 0.34
- MACD
- NNVC -0.06
- CLSD -0.16
- Stochastic Oscillator
- NNVC 3.95
- CLSD 10.47
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.